Intrapatient escape in the A*0201-restricted epitope SLYNTVATL drives evolution of human immunodeficiency virus type 1 at the population level. by Edwards, C, Pfafferott, K, Goulder, P, Phillips, R, Holmes, E

Full-length sequence analysis of HCV genotype-3A reveals novel regions of hypervariability by Humphreys, I, Park, L, Pfafferott, K, Gaudieri, S, Klenerman, P, Barnes, E

INTER-CONTINENTAL PATTERNS OF HIV-1 CONTROL: HLA AND THE QUEST FOR A T CELL VACCINE by Matthews, P, Prendergast, A, Kawashima, Y, Pfafferott, K, Frater, J, Heckerman, D, Takiguchi, M, Goulder, P

MULTIPLE NOVEL PEPTIDE EPITOPES IN HCV GENOTYPE-3A IDENTIFIED USING TWO PARALLEL APPROACHES by Boehmer, A, Pfafferott, K, Humphreys, I, Lucas, M, Swadling, L, Lauer, G, Gaudieri, S, Klenerman, P, Barnes, E

Comprehensive screening reveals strong and broadly directed human immunodeficiency virus type 1-specific CD8 responses in perinatally infected children. by Feeney, M, Roosevelt, K, Tang, Y, Pfafferott, K, McIntosh, K, Burchett, S, Mao, C, Walker, B, Goulder, P

The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design. by von Delft, A, Humphreys, I, Brown, A, Pfafferott, K, Lucas, M, Klenerman, P, Lauer, G, Cox, A, Gaudieri, S, Barnes, E

IL28B GENETIC STATUS IN ASSOCIATION WITH HCV SPECIFIC T-CELL IMMUNITY by Bucci, C, Rahman, M, Humphreys, I, Brown, A, Lucas, M, Pfafferott, K, Collier, J, O'Donnell, D, Stafford, E, Klenerman, P, Gaudieri, S, Barnes, E

Constrained pattern of viral evolution in acute and early HCV infection limits viral plasticity. by Pfafferott, K, Gaudieri, S, Ulsenheimer, A, James, I, Heeg, M, Nolan, D, John, M, Rauch, A, Mallal, S, Lucas, A, Klenerman, P, Diepolder, H, Lucas, M

Analysis of the Relationship Between Founder Virus Fitness, Primary T Cell Response Breadth and Viral Control in Acute HIV-1 Infection by Pfafferott, K, Yue, L, Baalwa, J, Salazar-Gonzalez, J, Conrod, K, Cormier, E, Gilmour, J, Karita, E, Sanders, E, Shaw, G, Hunter, E, Borrow, P

Full-length characterization of hepatitis C virus subtype 3a reveals novel hypervariable regions under positive selection during acute infection by Humphreys, I, Fleming, V, Fabris, P, Parker, J, Schulenberg, B, Brown, A, Demetriou, C, Gaudieri, S, Pfafferott, K, Lucas, M, Collier, J, Huang, K, Pybus, O, Klenerman, P, Barnes, E

Full-length characterization of hepatitis C virus subtype 3a reveals novel hypervariable regions under positive selection during acute infection. by Humphreys, I, Fleming, V, Fabris, P, Parker, J, Schulenberg, B, Brown, A, Demetriou, C, Gaudieri, S, Pfafferott, K, Lucas, M, Collier, J, Huang, K, Pybus, O, Klenerman, P, Barnes, E

Full-length characterization of hepatitis C virus subtype 3a reveals novel hypervariable regions under positive selection during acute infection (Journal of Virology (2009) 83, 22... by Humphreys, I, Fleming, V, Fabris, P, Parker, J, Schulenberg, B, Brown, A, Demetriou, C, Gaudieri, S, Pfafferott, K, Lucas, M, Collier, J, Huang, K, Pybus, O, Klenerman, P, Barnes, E

Full-Length Characterization of Hepatitis C Virus Subtype 3a Reveals Novel Hypervariable Regions under Positive Selection during Acute Infection (vol 83, pg 11456, 2009) by Humphreys, I, Fleming, V, Fabris, P, Parker, J, Schulenberg, B, Brown, A, Demetriou, C, Gaudieri, S, Pfafferott, K, Lucas, M, Collier, J, Huang, K, Pybus, O, Klenerman, P, Barnes, E

Relative resistance of HIV-1 founder viruses to control by interferon-alpha. by Fenton-May, A, Dibben, O, Emmerich, T, Ding, H, Pfafferott, K, Aasa-Chapman, M, Pellegrino, P, Williams, I, Cohen, MS, Gao, F, Shaw, G, Hahn, B, Ochsenbauer, C, Kappes, J, Borrow, P

Co-localisation of hepatitis C virus drug-resistant mutations and immune-driven adaptations for genotype 1 and 3: relevance to therapy outcome by Gaudieri, S, Rauch, A, Pfafferott, K, Barnes, E, Cheng, W, Mccaughan, G, Shackel, N, Jeffrey, G, Mollison, L, Baker, R, Furrer, H, Guenthard, H, Klenerman, P, Mallal, S, Roberts, S, Nolan, D, Lucas, M

Unique acquisition of cytotoxic T-lymphocyte escape mutants in infant human immunodeficiency virus type 1 infection. by Pillay, T, Zhang, H, Drijfhout, J, Robinson, N, Brown, H, Khan, M, Moodley, J, Adhikari, M, Pfafferott, K, Feeney, M, St John, A, Holmes, E, Coovadia, H, Klenerman, P, Goulder, P, Phillips, R

Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. by Martinez-Picado, J, Prado, J, Fry, E, Pfafferott, K, Leslie, A, Chetty, S, Thobakgale, C, Honeyborne, I, Crawford, H, Matthews, P, Pillay, T, Rousseau, C, Mullins, J, Brander, C, Walker, B, Stuart, D, Kiepiela, P, Goulder, P

HIV-1 viral escape in infancy followed by emergence of a variant-specific CTL response. by Feeney, M, Tang, Y, Pfafferott, K, Roosevelt, K, Draenert, R, Trocha, A, Yu, X, Verrill, C, Allen, T, Moore, C, Mallal, S, Burchett, S, McIntosh, K, Pelton, S, John, S, Hazra, R, Klenerman, P, Altfeld, M, Walker, B, Goulder, P

Passive sexual transmission of human immunodeficiency virus type 1 variants and adaptation in new hosts. by Frater, A, Edwards, C, McCarthy, N, Fox, J, Brown, H, Milicic, A, Mackie, N, Pillay, T, Drijfhout, J, Dustan, S, Clarke, JR, Holmes, E, Zhang, H, Pfafferott, K, Goulder, P, McClure, M, Weber, J, Phillips, R, Fidler, S

Hepatitis C virus drug resistance and immune-driven adaptations: relevance to new antiviral therapy. by Gaudieri, S, Rauch, A, Pfafferott, K, Barnes, E, Cheng, W, McCaughan, G, Shackel, N, Jeffrey, G, Mollison, L, Baker, R, Furrer, H, Günthard, H, Freitas, E, Humphreys, I, Klenerman, P, Mallal, S, James, I, Roberts, S, Nolan, D, Lucas, M